Cefuroxime axetil loaded solid lipid nanoparticles for enhanced activity against S. aureus biofilm

Colloids and Surfaces B: Biointerfaces

Volumn 121, Issue , 2014, Pages 92-98

  Singh, Bhupender ^a   Vuddanda, Parameswara Rao ^a   M R , Vijayakumar ^a   Kumar, Vinod ^b   Saxena, Preeti S ^b   Singh, Sanjay ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Binary lipids; Biofilms; Cefuroxime axetil; Microbial drug resistance; Nanoparticles

Indexed keywords

BACTERIA; DRUG INTERACTIONS; DYE-SENSITIZED SOLAR CELLS; ENCAPSULATION; LIPIDS; NANOPARTICLES; PARTICLE SIZE; SURFACE ACTIVE AGENTS;

CEFUROXIME AXETIL; DRUG RESISTANCE; DRUG-POLYMER INTERACTION; ENCAPSULATION EFFICIENCY; ENTRAPMENT EFFICIENCY; SOLID LIPID NANOPARTICLE (SLN); STAPHYLOCOCCUS AUREUS; SURFACTANT CONCENTRATIONS;

BIOFILMS;

CEFUROXIME AXETIL; SOLID LIPID NANOPARTICLE; STEARIC ACID; SURFACTANT; TRISTEARIN; CEFUROXIME; LIPID; NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOFILM; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG EFFICACY; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; DRUG SYNTHESIS; EMULSION; EVAPORATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; STATIC ELECTRICITY; ULTRASTRUCTURE;

BIOFILMS; CALORIMETRY, DIFFERENTIAL SCANNING; CEFUROXIME; DRUG STABILITY; LIPIDS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ATOMIC FORCE; NANOPARTICLES; PARTICLE SIZE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STAPHYLOCOCCUS AUREUS; STATIC ELECTRICITY;

EID: 84902511753     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.03.046     Document Type: Article

References (17)

1. Costerton J.W., Cheng K.J., Geesey G.G., Ladd T.I., Nickel C.J., Dasgupta M., Marrie T.J. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 1987, 41:435-464.
2. Manuel S., Lu cia C.S., Maria J.V. A review of current and emergent biofilm control strategies. LWT - Food Sci. Technol. 2010, 43:573-583.
3. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15:167-193.
4. Lewis K. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 2001, 45:999-1007.
5. Monzon M., Alvarez Garcia F., Lacleriga A., Gracia E., Leiva J., Oteiza C., Amorena B. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment. J. Orthop. Res. 2001, 19:820-826.
6. Sjostrom B., Bergenstahl B. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. Int. J. Pharm. 1992, 88:53-62.
7. Kushwaha A.K., Vuddanda P.R., Priyanka K., Singh S.K., Singh S. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. BioMed Res. Int. 2013, 2013:1-9.
8. Rawat M.K., Jain A., Mishra A., Muthu M.S., Singh S. Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method. Curr. Drug Deliv. 2010, 7:44-50.
9. Rawat M.K., Jain A., Singh S. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation. J. Pharm. Sci. 2011, 100(6):2366-2378.
10. Dhumal R.S., Biradar S.V., Yamamura S., Paradkar A.R., York P. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. Eur. J. Pharm. Biopharm. 2008, 70:109-115.
11. Lawrence Drew W., Barry A.L., Toole R.O., Sherris J.C. Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl. Microbiol. 1972, 24:240-247.
12. Bose S., Khodke M., Basak S., Mallick S.K. Detection of biofilm producing staphylococci: need of the hour. J. Clin. Diagn. Res. 2009, 3:1915-1920.
13. Cheow W.S., Chang M.W., Hadinoto K. The roles of lipid in anti-biofilm efficacy of lipid-polymer hybrid nanoparticles encapsulating antibiotics. Colloids Surf., A 2011, 389:158-165.
14. Merle E.O., Ceri H., Morck W.D., Buret G.A., Read R.R. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can. J. Vet. Res. 2002, 66:86-92.
15. Jenning V., Gohla S.H. Comparison of wax and glyceride solid lipid nanoparticles (SLN). Int. J. Pharm. 2000, 196:219-222.
16. Misra R., Acharya S., Dilnawaz F., Sahoo S.K. Sustained antibacterial activity of doxycycline-loaded poly (d,l-lactide-coglycolide) and poly(epsilon-caprolactone) nanoparticles. Nanomedicine 2009, 4:519-530.
17. Jeong Y.I., Na H.S., Seo D.H., Kim D.G., Lee H.C., Jang M.K. Ciprofloxacin-encapsulated poly (dl-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int. J. Pharm. 2008, 352:317-323.